News | September 29, 2025
AstraZeneca to harmonise its listing structure across LSE, STO and NYSE
Harmonisation of listing structure requires a direct listing of AstraZeneca shares on the NYSE in place of existing US ADRs
Harmonisation of listing structure requires a direct listing of AstraZeneca shares on the NYSE in place of existing US ADRs
Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
The vaccine was 85 percent effective in preventing severe disease across all regions.
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
Express Scripts has added YESINTEK to the National Preferred Formulary (NPF) effective March 21, 2025
The transaction structured as share swap, is valued at ~Rs. 849 crore, with no cash outflow
Subscribe To Our Newsletter & Stay Updated
